API5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.075400E-01
Normal-vs-Stage2
2.413800E-01
Normal-vs-Stage3
2.867800E-02
Normal-vs-Stage4
8.327800E-01
Stage1-vs-Stage2
7.236600E-01
Stage1-vs-Stage3
7.183700E-02
Stage1-vs-Stage4
5.069800E-01
Stage2-vs-Stage3
1.246010E-01
Stage2-vs-Stage4
2.973600E-01
Stage3-vs-Stage4
7.696400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.498400E-01
Normal-vs-AfricanAmerican
4.990600E-01
Normal-vs-Asian
8.604500E-02
Caucasian-vs-AfricanAmerican
6.375400E-01
Caucasian-vs-Asian
3.299400E-01
AfricanAmerican-vs-Asian
2.967000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.434000E-01
Normal-vs-Female
2.784800E-01
Male-vs-Female
4.804200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.650100E-02
Normal-vs-Age(41-60Yrs)
5.179200E-01
Normal-vs-Age(61-80Yrs)
1.904220E-01
Normal-vs-Age(81-100Yrs)
8.565500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.685200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.430400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.271400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.615790E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.734500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.665900E-02
Normal-vs-Daily Drinker
5.607900E-02
Normal-vs-Weekly Drinker
1.037170E-01
Normal-vs-Occasional Drinker
6.967400E-01
Normal-vs-Social Drinker
5.503000E-01
Non Drinker-vs-Daily Drinker
7.241000E-01
Non Drinker-vs-Weekly Drinker
9.086400E-01
Non Drinker-vs-Occasional Drinker
6.800000E-02
Non Drinker-vs-Social Drinker
6.353700E-02
Daily Drinker-vs-Weekly Drinker
7.006600E-01
Daily Drinker-vs-Occasional Drinker
3.876400E-02
Daily Drinker-vs-Social Drinker
5.546000E-02
Weekly Drinker-vs-Occasional Drinker
1.357220E-01
Weekly Drinker-vs-Social Drinker
1.681750E-01
Occasional Drinker-vs-Social Drinker
8.210000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.876560E-01
Normal-vs-Grade 2
8.996400E-02
Normal-vs-Grade 3
7.863500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.511600E-01
Grade 1-vs-Grade 3
4.777600E-01
Grade 1-vs-Grade 4
1.876560E-01
Grade 2-vs-Grade 3
5.467600E-01
Grade 2-vs-Grade 4
8.996400E-02
Grade 3-vs-Grade 4
7.863500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.174350E-01
Normal-vs-NonDiabetic
1.884800E-01
Diabetic-vs-NonDiabetic
4.193200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.374300E-02
Normal-vs-NoPancreatitis
1.908210E-01
Pancreatitis-vs-NoPancreatitis
3.578400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.425200E-01
Normal-vs-N1
2.384600E-01
N0-vs-N1
6.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.401600E-01
Normal-vs-TP53-NonMutant
4.970800E-01
TP53-Mutant-vs-TP53-NonMutant
4.515400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
